Quell Therepeutics

PITCH

At Quell we seek to deliver truly innovative, life-changing therapies for our patients. Our vision as a company is to build a major global biopharmaceutical company bringing transformational and valued therapies for a range of autoimmune and inflammatory diseases, as well as preventing rejection in organ transplantation, based on modular engineered Tregs.

Based in

London

Created in

> Website

LATEST INVESTMENT

#Healthtech 11.2021

£117M

Fidelity, Tekla Capital Management, Point72 Ventures, SV Health Investors, Future Fund, Janus Henderson Investors, Breakthrough Energy Ventures, Ridgeback Capital, British Patient Capital (BPC), Syncona, Monashee Investment Management & Jeito Capital

#Healthtech 02.2021

£60.4M

Syncona Ltd & UCL Technology Fund